Trial · NCT05073679
Registered outcomes62
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 62
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | ED-15 Score | Time Frame: Measured at the following timepoints: enrollment | ED-15 is an evidenced-based metric of eating disorder symptom severity and frequency. The global score ranges from a 0 to 6 with higher scores indicating more eating disordered psychopathology. |
| Primary | ED-15 Score | Time Frame: Measured at the following timepoints: one week | ED-15 is an evidenced-based metric of eating disorder symptom severity and frequency. The global score ranges from a 0 to 6 with higher scores indicating more eating disordered psychopathology. |
| Primary | ED-15 Score | Time Frame: Measured at the following timepoints: three week | ED-15 is an evidenced-based metric of eating disorder symptom severity and frequency. The global score ranges from a 0 to 6 with higher scores indicating more eating disordered psychopathology. |
| Primary | ED-15 Score | Time Frame: Measured at the following timepoints: six weeks | ED-15 is an evidenced-based metric of eating disorder symptom severity and frequency. The global score ranges from a 0 to 6 with higher scores indicating more eating disordered psychopathology. |
| Primary | ED-15 Score | Time Frame: Measured at the following timepoints: nine weeks (last week of treatment) | ED-15 is an evidenced-based metric of eating disorder symptom severity and frequency. The global score ranges from a 0 to 6 with higher scores indicating more eating disordered psychopathology. |
| Primary | ED-15 Score | Time Frame: Measured at the following timepoints: 6 months after enrollment | ED-15 is an evidenced-based metric of eating disorder symptom severity and frequency. The global score ranges from a 0 to 6 with higher scores indicating more eating disordered psychopathology. |
| Secondary | Eating Disorder Examination Questionnaire Score (EDE-Q) | Measured at the following timepoints: enrollment | EDE-Q is an evidence-based metric of eating disorder severity. The global EDE-Q score ranges from 0 to 6, with higher scores indicating a higher eating disorder psychopathology. |
| Secondary | Eating Disorder Examination Questionnaire Score (EDE-Q) | Measured at the following timepoints: one week | EDE-Q is an evidence-based metric of eating disorder severity. The global EDE-Q score ranges from 0 to 6, with higher scores indicating a higher eating disorder psychopathology. |
| Secondary | Eating Disorder Examination Questionnaire Score (EDE-Q) | Measured at the following timepoints: three weeks | EDE-Q is an evidence-based metric of eating disorder severity. The global EDE-Q score ranges from 0 to 6, with higher scores indicating a higher eating disorder psychopathology. |
| Secondary | Eating Disorder Examination Questionnaire Score (EDE-Q) | Measured at the following timepoints: six weeks | EDE-Q is an evidence-based metric of eating disorder severity. The global EDE-Q score ranges from 0 to 6, with higher scores indicating a higher eating disorder psychopathology. |
| Secondary | Eating Disorder Examination Questionnaire Score (EDE-Q) | Measured at the following timepoints: nine weeks (last week of treatment) | EDE-Q is an evidence-based metric of eating disorder severity. The global EDE-Q score ranges from 0 to 6, with higher scores indicating a higher eating disorder psychopathology. |
| Secondary | Eating Disorder Examination Questionnaire Score (EDE-Q) | Measured at the following timepoints: 6 months after enrollment | EDE-Q is an evidence-based metric of eating disorder severity. The global EDE-Q score ranges from 0 to 6, with higher scores indicating a higher eating disorder psychopathology. |
| Secondary | Patient Health Questionnaire Score (PHQ-9) | Measured at the following timepoints: enrollment | Evidence-based metric of depression, min = 0, max= 27, higher scores indicate more severe depression |
| Secondary | Patient Health Questionnaire Score (PHQ-9) | Measured at the following timepoints: one week | Evidence-based metric of depression, min = 0, max= 27, higher scores indicate more severe depression |
| Secondary | Patient Health Questionnaire Score (PHQ-9) | Measured at the following timepoints: three weeks | Evidence-based metric of depression, min = 0, max= 27, higher scores indicate more severe depression |
| Secondary | Patient Health Questionnaire Score (PHQ-9) | Measured at the following timepoints: six weeks | Evidence-based metric of depression, min = 0, max= 27, higher scores indicate more severe depression |
| Secondary | Patient Health Questionnaire Score (PHQ-9) | Measured at the following timepoints: nine weeks (last week of treatment) | Evidence-based metric of depression, min = 0, max= 27, higher scores indicate more severe depression |
| Secondary | Patient Health Questionnaire Score (PHQ-9) | Measured at the following timepoints: 6 months after enrollment | Evidence-based metric of depression, min = 0, max= 27, higher scores indicate more severe depression |
| Secondary | Generalized Anxiety Disorder Screener Score (GAD-7) | Measured at the following timepoints: enrollment | evidence-based metric of anxiety, min=0, max=21, higher scores indicate more severe anxiety |
| Secondary | Generalized Anxiety Disorder Screener Score (GAD-7) | Measured at the following timepoints: one week | evidence-based metric of anxiety, min=0, max=21, higher scores indicate more severe anxiety |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05073679/registered